Behbahani Aliinsider trades
In SEC Form 4 filings, Behbahani Ali is listed as Director of CRISPR Therapeutics AG (CRSP) and Director of Black Diamond Therapeutics, Inc. (BDTX). In the last 90 days, Behbahani Ali sold $780.9K of CRISPR Therapeutics AG (CRSP) on the open market and bought none.
Companies and roles
Cluster buys
No cluster buy in the last 90 days included a purchase by this insider (two or more insiders buying within 14 days).
Form 4 historysince 2026-09-21
| Company | Traded | Filed | Type | Shares | Price | Value | Owned after | 10b5-1 plan | Filing |
|---|---|---|---|---|---|---|---|---|---|
| BDTXBlack Diamond Therapeutics, Inc. | Sep 18 | Sep 21 | A | 7,707 | $1.93 | $14,875 | 110,236 | No | Form 4 |
| CRSPCRISPR Therapeutics AG | Sep 17 | Sep 21 | M | 30,000 | $14.00 | $420,000 | 30,316 | No | Form 4 |
| CRSPCRISPR Therapeutics AG | Sep 17 | Sep 21 | S | 13,679 | $57.09 | Sale −$780,935 | 16,637 | No | Form 4 |
| CRSPCRISPR Therapeutics AG | Sep 17 | Sep 21 | M · derivative | 30,000 | $14.00 | $420,000 | not reported | No | Form 4 |
| CRSPCRISPR Therapeutics AG | Aug 6, 2025 | Sep 21 | J | 60 | $0.00 | $0 | 316 | No | Form 4 |
| CRSPCRISPR Therapeutics AG | Aug 6, 2025 | Sep 21 | J | 15 | $0.00 | $0 | 29 | No | Form 4 |
Published from this insider's public Form 4 filings on SEC EDGAR; the name is shown as filed. Named in a filing and want this page removed? See the privacy policy.